Literature DB >> 25778927

Characterization of cyclic peptides containing disulfide bonds.

Mindy Johnson1, Mingtao Liu1, Elaine Struble1, Kanthi Hettiarachchi2.   

Abstract

Unlike linear peptides, analysis of cyclic peptides containing disulfide bonds is not straightforward and demands indirect methods to achieve a rigorous proof of structure. Three peptides that belong to this category, p-Cl-Phe-DPDPE, DPDPE, and CTOP, were analyzed and the results are presented in this paper. The great potential of two dimensional NMR and ESI tandem mass spectrometry was harnessed during the course of peptide characterizations. A new RP-HPLC method for the analysis of trifluoroacetic acid is also presented. It is robust, simple, and efficient compared to the currently available methods.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Opioid peptides; RP-HPLC; Tandem mass spectrometry; Trifluoroacetic acid; Two-dimensional NMR

Mesh:

Substances:

Year:  2015        PMID: 25778927      PMCID: PMC4608431          DOI: 10.1016/j.jpba.2015.01.009

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  20 in total

1.  Characterization and analysis of biphalin: an opioid peptide with a palindromic sequence.

Authors:  K Hettiarachchi; S Ridge; D W Thomas; L Olson; C R Obi; D Singh
Journal:  J Pept Res       Date:  2001-02

2.  DITHIOTHREITOL, A NEW PROTECTIVE REAGENT FOR SH GROUPS.

Authors:  W W CLELAND
Journal:  Biochemistry       Date:  1964-04       Impact factor: 3.162

Review 3.  Conformationally restricted peptides as tools in opioid receptor studies.

Authors:  Anna Janecka; Rafal Kruszynski
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

Review 4.  Development of delta opioid peptides as nonaddicting analgesics.

Authors:  R S Rapaka; F Porreca
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

5.  A comparison between the sulfhydryl reductants tris(2-carboxyethyl)phosphine and dithiothreitol for use in protein biochemistry.

Authors:  E B Getz; M Xiao; T Chakrabarty; R Cooke; P R Selvin
Journal:  Anal Biochem       Date:  1999-08-15       Impact factor: 3.365

Review 6.  Design of peptide and peptidomimetic ligands with novel pharmacological activity profiles.

Authors:  Victor J Hruby; Minying Cai
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013       Impact factor: 13.820

Review 7.  Design of novel synthetic peptides including cyclic conformationally and topographically constrained analogs.

Authors:  V J Hruby; G G Bonner
Journal:  Methods Mol Biol       Date:  1994

Review 8.  Cyclization in opioid peptides.

Authors:  Justyna Piekielna; Renata Perlikowska; Katarzyna Gach; Anna Janecka
Journal:  Curr Drug Targets       Date:  2013-06       Impact factor: 3.465

Review 9.  Opioid peptide-derived analgesics.

Authors:  Peter W Schiller
Journal:  AAPS J       Date:  2005-10-14       Impact factor: 4.009

10.  On-line electrochemical reduction of disulfide bonds: improved FTICR-CID and -ETD coverage of oxytocin and hepcidin.

Authors:  Simone Nicolardi; Martin Giera; Pieter Kooijman; Agnieszka Kraj; Jean-Pierre Chervet; André M Deelder; Yuri E M van der Burgt
Journal:  J Am Soc Mass Spectrom       Date:  2013-09-10       Impact factor: 3.109

View more
  3 in total

1.  Gold(I) Cationization Promotes Ring Opening in Lysine-Containing Cyclic Peptides.

Authors:  David J Foreman; John T Lawler; Mary L Niedrauer; Matthew A Hostetler; Scott A McLuckey
Journal:  J Am Soc Mass Spectrom       Date:  2019-06-27       Impact factor: 3.109

2.  Opioid Receptor Activity and Analgesic Potency of DPDPE Peptide Analogues Containing a Xylene Bridge.

Authors:  Azzurra Stefanucci; Ettore Novellino; Sako Mirzaie; Giorgia Macedonio; Stefano Pieretti; Paola Minosi; Edina Szűcs; Anna I Erdei; Ferenc Zádor; Sándor Benyhe; Adriano Mollica
Journal:  ACS Med Chem Lett       Date:  2017-03-14       Impact factor: 4.345

Review 3.  On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site.

Authors:  Eirinaios I Vrettos; Gábor Mező; Andreas G Tzakos
Journal:  Beilstein J Org Chem       Date:  2018-04-26       Impact factor: 2.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.